Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial
- PMID: 21784145
- PMCID: PMC3191260
- DOI: 10.1016/j.bbi.2011.07.229
Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial
Abstract
Observational studies have linked lower omega-3 (n-3) polyunsaturated fatty acids (PUFAs) and higher omega-6 (n-6) PUFAs with inflammation and depression, but randomized controlled trial (RCT) data have been mixed. To determine whether n-3 decreases proinflammatory cytokine production and depressive and anxiety symptoms in healthy young adults, this parallel group, placebo-controlled, double-blind 12-week RCT compared n-3 supplementation with placebo. The participants, 68 medical students, provided serial blood samples during lower-stress periods as well as on days before an exam. The students received either n-3 (2.5 g/d, 2085 mg eicosapentaenoic acid and 348 mg docosahexanoic acid) or placebo capsules that mirrored the proportions of fatty acids in the typical American diet. Compared to controls, those students who received n-3 showed a 14% decrease in lipopolysaccharide (LPS) stimulated interleukin 6 (IL-6) production and a 20% reduction in anxiety symptoms, without significant change in depressive symptoms. Individuals differ in absorption and metabolism of n-3 PUFA supplements, as well as in adherence; accordingly, planned secondary analyses that used the plasma n-6:n-3 ratio in place of treatment group showed that decreasing n-6:n-3 ratios led to lower anxiety and reductions in stimulated IL-6 and tumor necrosis factor alpha (TNF-α) production, as well as marginal differences in serum TNF-α. These data suggest that n-3 supplementation can reduce inflammation and anxiety even among healthy young adults. The reduction in anxiety symptoms associated with n-3 supplementation provides the first evidence that n-3 may have potential anxiolytic benefits for individuals without an anxiety disorder diagnosis. ClinicalTrials.gov identifier: NCT00519779.
Copyright © 2011 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest statement: All authors declare that there are no conflicts of interest.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3191260/bin/nihms312102f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3191260/bin/nihms312102f2.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/3191260/bin/nihms312102f3.gif)
Similar articles
-
Omega-3 supplementation lowers inflammation in healthy middle-aged and older adults: a randomized controlled trial.Brain Behav Immun. 2012 Aug;26(6):988-95. doi: 10.1016/j.bbi.2012.05.011. Epub 2012 May 26. Brain Behav Immun. 2012. PMID: 22640930 Free PMC article. Clinical Trial.
-
Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: A randomized controlled trial.Brain Behav Immun. 2013 Feb;28:16-24. doi: 10.1016/j.bbi.2012.09.004. Epub 2012 Sep 23. Brain Behav Immun. 2013. PMID: 23010452 Free PMC article. Clinical Trial.
-
Potential therapeutic impact of omega-3 long chain-polyunsaturated fatty acids on inflammation markers in Duchenne muscular dystrophy: A double-blind, controlled randomized trial.Clin Nutr. 2018 Dec;37(6 Pt A):1840-1851. doi: 10.1016/j.clnu.2017.09.011. Epub 2017 Sep 23. Clin Nutr. 2018. PMID: 28987470 Clinical Trial.
-
Polyunsaturated fatty acid supplementation for drug-resistant epilepsy.Cochrane Database Syst Rev. 2016 Aug 17;2016(8):CD011014. doi: 10.1002/14651858.CD011014.pub2. Cochrane Database Syst Rev. 2016. PMID: 27536971 Free PMC article. Review.
-
[Lipids, depression and suicide].Encephale. 2003 Jan-Feb;29(1):49-58. Encephale. 2003. PMID: 12640327 Review. French.
Cited by
-
Diet quality and anxiety: a critical overview with focus on the gut microbiome.Front Nutr. 2024 May 15;11:1346483. doi: 10.3389/fnut.2024.1346483. eCollection 2024. Front Nutr. 2024. PMID: 38812941 Free PMC article.
-
N-3 PUFA supplementation alleviates anxiety symptoms by manipulating erythrocyte fatty acid levels in depression.Eur J Nutr. 2024 May 17. doi: 10.1007/s00394-024-03421-y. Online ahead of print. Eur J Nutr. 2024. PMID: 38758363
-
Interventions to promote medical student well-being: an overview of systematic reviews.BMJ Open. 2024 May 9;14(5):e082910. doi: 10.1136/bmjopen-2023-082910. BMJ Open. 2024. PMID: 38724055 Free PMC article. Review.
-
Test Anxiety Among US Medical Students: A Review of the Current Literature.Med Sci Educ. 2024 Feb 14;34(2):491-499. doi: 10.1007/s40670-024-01999-w. eCollection 2024 Apr. Med Sci Educ. 2024. PMID: 38686157 Review.
-
Depression in Women: Potential Biological and Sociocultural Factors Driving the Sex Effect.Neuropsychobiology. 2024;83(1):2-16. doi: 10.1159/000531588. Epub 2024 Jan 25. Neuropsychobiology. 2024. PMID: 38272005 Free PMC article. Review.
References
-
- Intakes of 19 individual fatty acids: results from 1994–96, continuing survey of food intakes by individuals. U. S. Department of Agriculture, Agricultural Research Service. http://www.barc.usda.gov/bhnrc/foodsurvey/home.htm.
-
- Appleton KM, Rogers PJ, Ness AR. Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am. J. Clin. Nutr. 2010;91:757–770. - PubMed
-
- Basco MR, Krebaum SR, Rush AJ. Outcome measures of depression. In: Strupp HH, Horowitz LM, Lambert MJ, editors. Measuring patient changes in mood, anxiety, and personality disorders. Washington D. C.: American Psychological Association; 1997. pp. 207–245.
-
- Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: Psychometric properties. J. Consult. Clin. Psychol. 1988;56:893–897. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- UL1 RR025755-05/RR/NCRR NIH HHS/United States
- CA16058/CA/NCI NIH HHS/United States
- UL1RR025755/RR/NCRR NIH HHS/United States
- R21 AT003912/AT/NCCIH NIH HHS/United States
- R21 AT003912-01A1/AT/NCCIH NIH HHS/United States
- UL1 RR025755/RR/NCRR NIH HHS/United States
- AT003912/AT/NCCIH NIH HHS/United States
- P30 CA016058-34/CA/NCI NIH HHS/United States
- R21 AT003912-02/AT/NCCIH NIH HHS/United States
- R21 AT003912-02S1/AT/NCCIH NIH HHS/United States
- P30 CA016058/CA/NCI NIH HHS/United States
- R21 AT003912-02S2/AT/NCCIH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical